Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 Oct 26;303(6809):1062–1063. doi: 10.1136/bmj.303.6809.1062-c

Use of thalidomide in leprosy.

C L Crawford
PMCID: PMC1671731  PMID: 1954472

Full text

PDF
1062

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crawford C. L. Nature of the sensory loss in leprosy. Muscle Nerve. 1988 Mar;11(3):276–278. doi: 10.1002/mus.880110314. [DOI] [PubMed] [Google Scholar]
  2. Crawford C. L. Treatment of erythema nodosum leprosum with thalidomide. Lancet. 1973 Sep 8;2(7828):567–568. doi: 10.1016/s0140-6736(73)92391-x. [DOI] [PubMed] [Google Scholar]
  3. Hess C. W., Hunziker T., Küpfer A., Ludin H. P. Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation. J Neurol. 1986 Apr;233(2):83–89. doi: 10.1007/BF00313852. [DOI] [PubMed] [Google Scholar]
  4. Knop J., Bonsmann G., Happle R., Ludolph A., Matz D. R., Mifsud E. J., Macher E. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol. 1983 Apr;108(4):461–466. doi: 10.1111/j.1365-2133.1983.tb04600.x. [DOI] [PubMed] [Google Scholar]
  5. Levy L., Fasal P., Levan N. E., Freedman R. I. Treatment of erythema nodosum leprosum with thalidomide. Lancet. 1973 Aug 11;2(7824):324–325. doi: 10.1016/s0140-6736(73)90829-5. [DOI] [PubMed] [Google Scholar]
  6. Waters M. F. Use of thalidomide in leprosy. BMJ. 1991 Aug 24;303(6800):470–470. doi: 10.1136/bmj.303.6800.470-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES